These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10082721)

  • 1. Trends in deaths from malignant neoplasia of liver are poor indicator of hepatitis C infection.
    Harris HE; Ramsay ME; Balogun K; Alexander GJ
    BMJ; 1999 Mar; 318(7186):808-9. PubMed ID: 10082721
    [No Abstract]   [Full Text] [Related]  

  • 2. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C. Why all the fuss?
    McCreaddie M; Neilson M
    Nurs Times; 2001 Mar 15-21; 97(11):34-7. PubMed ID: 11954352
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of hepatocellular carcinoma in Japan.
    Kiyosawa K; Tanaka E
    Oncology; 2002; 62 Suppl 1():5-7. PubMed ID: 11868786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.
    Amin J; Law MG; Bartlett M; Kaldor JM; Dore GJ
    Lancet; 2006 Sep; 368(9539):938-45. PubMed ID: 16962883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.
    Cacoub P; Geffray L; Rosenthal E; Perronne C; Veyssier P; Raguin G;
    Clin Infect Dis; 2001 Apr; 32(8):1207-14. PubMed ID: 11283811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India.
    Islami F; Dikshit R; Mallath MK; Jemal A
    Cancer Epidemiol; 2016 Feb; 40():79-86. PubMed ID: 26683034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression analysis of trends in mortality from hepatocellular carcinoma in Japan, 1972-2001.
    Shibuya K; Yano E
    Int J Epidemiol; 2005 Apr; 34(2):397-402. PubMed ID: 15561746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid fibrosis and significant histologic recurrence of hepatitis C after liver transplant is associated with higher tumor recurrence rates in hepatocellular carcinomas associated with hepatitis C virus-related liver disease: a single center retrospective analysis.
    Vasavada BB; Chan CL
    Exp Clin Transplant; 2015 Feb; 13(1):46-50. PubMed ID: 25654412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality trend for liver cancer in a hyperendemic area of hepatitis C virus infection in southern Italy: join-point analysis and comparison with European and Italian data.
    Crispo A; Barba M; Malvezzi M; Ciliberto G; Montella M
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):245-6. PubMed ID: 24366455
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in primary liver cancer.
    Deuffic S; Poynard T; Buffat L; Valleron AJ
    Lancet; 1998 Jan; 351(9097):214-5. PubMed ID: 9449893
    [No Abstract]   [Full Text] [Related]  

  • 12. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C virus infection, its burden and countermeasures from the epidemiological point of view].
    Tanaka J; Aizaki H; Uchida S
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():89-97. PubMed ID: 26845910
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of HCV infection and second neoplasms in marginal zone lymphomas.
    Luppi M; Longo G; Ferrari MG; Ferrara L; Marasca R; Barozzi P; Morselli M; Emilia G; Torelli G
    Br J Haematol; 1997 Mar; 96(4):873-4. PubMed ID: 9074436
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in liver cancer mortality rates in Japan, USA, UK, France and Korea based on the WHO mortality database.
    Matsuda T; Saika K
    Jpn J Clin Oncol; 2012 Apr; 42(4):360-1. PubMed ID: 22457364
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply: To PMID 24677195.
    Mourad A; Mathurin P; Deuffic-Burban S
    Gastroenterology; 2014 Oct; 147(4):936-7. PubMed ID: 25150789
    [No Abstract]   [Full Text] [Related]  

  • 17. The pattern of late mortality in liver transplant recipients in the United Kingdom.
    Gelson W; Hoare M; Dawwas MF; Vowler S; Gibbs P; Alexander G
    Transplantation; 2011 Jun; 91(11):1240-4. PubMed ID: 21516069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does surveillance for hepatocellular carcinoma benefit patients with compensated cirrhosis?
    Yopp A; Waljee A; Singal AG
    Gastroenterology; 2014 Oct; 147(4):935-6. PubMed ID: 25150788
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of hepatitis C virus in hepatocellular carcinoma in Japan.
    Kaneko S; Unoura M; Takeuchi M; Terasaki S; Ogino H; Matsushita E; Kobayashi K
    Intervirology; 1994; 37(2):108-13. PubMed ID: 7529218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.
    Kumada H
    Oncology; 2002; 62 Suppl 1():94-100. PubMed ID: 11868794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.